The nephroprotective effect of some vasodilators and vitamins in experimental model of acute renal failure

Authors

  • Rana Muhsin Khalaf Department of pharmacology and therapeutics-college of medicine-Al-Nahrain University
  • Faruk H. Aljawad Department of pharmacology and therapeutics-college of medicine-Al-Nahrain University

Keywords:

nephroprotective, vasodilators, vitamins, acute renal failure

Abstract

Background: Myoglobinuric ARF is an example of intrinsic type of renal failure induced by intramuscular injection of glycerol. Materials and methods: this study has been conducted using 36 local domestic rabbits. They were separated in to 6 groups, each one has been pre-treated with a test agent (vitamin C and E, amlodipine, carvedilol and verapamil) 2 hours prior to administration of glycerol. The changes in renal function have been followed up by monitoring the levels of BUN, serum creatinine, K­+and Na+ after 3 and 7 days of the induction.Results: pretreatment with vitamin C, vitamin E, carvedilol and verapamil cause significant reduction in the levels of BUN, serum creatinine and K­+ and significant elevation of serum Na+when compared with the control group. While pretreatment with amlodipine causes significant elevation of BUN, serum creatinine and K­+. Conclusion: Vitamin C, E, carvedilol and verapamil have a significant nephroprotective effect at the tested doses in this model of acute renal failure with a possible use in prevention of acute renal failure.

References

Braunwald, Fauci and Kasper:" Harrisons' principles of internal medicine", 15Th ed., volume 2. McGraw Hill Medical Publishing Division-NewYork, 2001: 1541-50.

Sauret J.M., Marinides G. and Wang G.K. "Rhabdomyolysis": Am. Fam. Physician, 2002; 65: 907-12.

Antonio Bianchi, Paola Cantu' and Fabio Firenzuol.: "Rhabdomyolysis caused by Commiphora mukul, a natural lipid-lowering agent". The Annals of Phamacotherapy, 2004 July/ August; Vol. 32: 2-3.

Carl A. Burtis and Edward R. Ashood: "Tietz textbook of clinical chemistry", 3rd ed., volume 2. W. B. Sanders Company, 1999: 1003, 1059-60.

Holt S. and Moore K. "Pathogenesis of ARF in rhabdomyolysis, the role of myoglobin". Exp Nephrol, 2000; 8: 72-6.

Angel Fernandez-Funez, Francisco J. and Luis Broseta: "Evaluation of total antioxidant status in a model of acute renal failure insufficiency in rats". Renal failure, 2003; 25(4): 535-43.

Robert W. Schrier and Carl W. Gottschalk: "Diseases of the kidney", 6th ed., vol.2. Little Brown and Boston Co., 1996:1273-99.

Christopher Haslett, Edwin R. Chilvers, John A.A Hunter and Nicholas A.Boon: "Davidson,s principles and practice of medicine", 19th ed.. Churchill Living-stone, 2002: 594-99.

Greggi-Antunes L.M., Darin J.D. and Bianchi M.D.: "protective effect of vitamin C against cisplatin induced nephrotoxicity and lipid peroxidation in adult rats: a dose dependant study ". Parmacol. Res., 2000 Apr; 41(2): 405-

Parra-Cid T., Conejo-Garcia J.R. and Carbello- Alvarez F.: "Antioxidant nutrients protect against cyclosporine A nephro-toxicity". Toxicology, 2003 Jul 15; 189 (1-2): 19-111

Padi S.S. and Chopra K.: "Salvage of cyclosporine A induced oxidative stress and renal dysfunction by carvedilol". Nephron, 2002; 29(3): 685-92.

Dzgeove F.U. and Kutyrina I. M.: "Thromboxane A2 and prostacyclin in patients with chronic glomerulonephritis and coronary heart disease in contrast media nehrotoxicity, protective effect of calcium antagonists". Ter. Arkh., 2000; 72 (6): 42-5.

Downloads

Published

2021-10-30

Issue

Section

ARTICLE